Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vitale, M.
Right arrow Articles by Moretta, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vitale, M.
Right arrow Articles by Moretta, A.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 March 2002, Vol. 99, No. 5, pp. 1723-1729

IMMUNOBIOLOGY

Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells

Massimo Vitale, Jacques Zimmer, Roberta Castriconi, Daniel Hanau, Lionel Donato, Cristina Bottino, Lorenzo Moretta, Henri de la Salle, and Alessandro Moretta

From the Istituto Nazionale per la Ricerca sul Cancro, Genova, the Dipartimento di Medicina Sperimentale, Università di Genova, and the Istituto Giannina Gaslini, Genova, Italy; INSERM EP 99-08 Etablissement Francais du Sang-Alsace, Strasbourg, and Service de Pediatrie, Hopital de Hautepierre, Strasbourg, France.

Natural killer (NK) cells are characterized by the ability to kill cells that lack HLA class I molecules while sparing autologous normal (HLA class I+) cells. However, patients with transporter-associated antigen processing (TAP) deficiency, though displaying strong reductions of HLA class I surface expression, in most instances do not experience NK-mediated autoimmune phenomena. A possible mechanism by which TAP-/- NK cells avoid autoreactivity against autologous HLA class I-deficient cells could be based on either quantitative or qualitative defects of surface receptors involved in NK cell triggering. In this study we show that NK cells derived from 2 patients with TAP2-/- express normal levels of all known triggering receptors. As revealed by the analysis of polyclonal and clonal NK cells, these receptors display normal functional capabilities and allow the killing of a panel of NK-susceptible targets, including autologous B-LCLs. On the other hand, TAP2-/- NK cells were unable to kill either allogeneic (HLA class I+) or autologous (HLA class I- ) phytohemagglutinin (PHA) blasts even in the presence of anti-HLA class I monoclonal antibody. These data suggest that TAP2-/- NK cells express still unknown inhibitory receptor(s) capable of down-regulating the NK cell cytotoxicity on binding to surface ligand(s) expressed by T cell blasts. Functional analyses, both at the polyclonal and at the clonal level, are consistent with the concept that the putative inhibitory receptor is expressed by virtually all TAP2-/- NK cells, whereas it is present only in rare NK cells from healthy persons. Another possibility would be that TAP2-/- NK cells are missing a still unidentified triggering receptor involved in NK cell-mediated killing of PHA blasts.

© 2002 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
N. T. Joncker, N. C. Fernandez, E. Treiner, E. Vivier, and D. H. Raulet
NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model
J. Immunol., April 15, 2009; 182(8): 4572 - 4580.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. A. Caligiuri
Human natural killer cells
Blood, August 1, 2008; 112(3): 461 - 469.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Benoit and R. Tan
Xenogeneic beta2-Microglobulin Substitution Alters NK Cell Function
J. Immunol., August 1, 2007; 179(3): 1466 - 1474.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. H. Chewning, C. N. Gudme, K. C. Hsu, A. Selvakumar, and B. Dupont
KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro
J. Immunol., July 15, 2007; 179(2): 854 - 868.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Grzywacz, N. Kataria, M. Sikora, R. A. Oostendorp, E. A. Dzierzak, B. R. Blazar, J. S. Miller, and M. R. Verneris
Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells
Blood, December 1, 2006; 108(12): 3824 - 3833.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Hanna, H. Mussaffi, G. Steuer, S. Hanna, M. Deeb, H. Blau, T. I. Arnon, N. Weizman, and O. Mandelboim
Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency
Blood, November 15, 2005; 106(10): 3465 - 3473.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
J. Zimmer, E. Andres, L. Donato, D. Hanau, F. Hentges, and H. de la Salle
Clinical and immunological aspects of HLA class I deficiency
QJM, October 1, 2005; 98(10): 719 - 727.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. E. McNerney, D. Guzior, and V. Kumar
2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK-cell self-tolerance in mice
Blood, August 15, 2005; 106(4): 1337 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Le Discorde, C. Le Danff, P. Moreau, N. Rouas-Freiss, and E. D. Carosella
HLA-G*0105N Null Allele Encodes Functional HLA-G Isoforms
Biol Reprod, August 1, 2005; 73(2): 280 - 288.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K.-M. Lee, M. E. McNerney, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennett, and V. Kumar
2B4 Acts As a Non-Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells
J. Exp. Med., May 3, 2004; 199(9): 1245 - 1254.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Markel, H. Mussaffi, K.-L. Ling, M. Salio, S. Gadola, G. Steuer, H. Blau, H. Achdout, M. de Miguel, T. Gonen-Gross, et al.
The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients
Blood, March 1, 2004; 103(5): 1770 - 1778.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Voehringer, M. Koschella, and H. Pircher
Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)
Blood, November 15, 2002; 100(10): 3698 - 3702.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Sivori, M. Falco, E. Marcenaro, S. Parolini, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation
PNAS, March 21, 2002; (2002) 72065999.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Sivori, M. Falco, E. Marcenaro, S. Parolini, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation
PNAS, April 2, 2002; 99(7): 4526 - 4531.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020